Thank you! Your submission has been received!
It looks like that email is already in our system - thanks for signing up!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
×
back to team︁
Kevin Chapman

Investments

No Current Investments
-
Kevin Chapman

Connect With

Kevin Chapman

Kevin Chapman

Advisor

Prior Experience

Kevin Chapman is an Advisor to Celesta. Holding more than 50 US and international patents, his background lies in pharmaceutical discovery and technology development for target validation, biomarker discovery, and medicinal and combinatorial chemistry. Prior to Celesta, Kevin was Chief Science Officer of Berkeley Lights for eight years and for 20 years, he held various senior management roles at Merck & Co.

Focus Areas

MedTech
Life Sciences

Boards

Education

Kevin Chapman

Kevin Chapman

Advisor

Prior Experience

Kevin Chapman is an Advisor to Celesta. Holding more than 50 US and international patents, his background lies in pharmaceutical discovery and technology development for target validation, biomarker discovery, and medicinal and combinatorial chemistry. Prior to Celesta, Kevin was Chief Science Officer of Berkeley Lights for eight years and for 20 years, he held various senior management roles at Merck & Co.

Focus Areas

MedTech
Life Sciences

Boards

Education

Investments

No Current Investments
-
Kevin Chapman

Connect With

Kevin Chapman